Statin-related pain is not reduced by vitamin D therapy, researchers reported on Nov. 23, 2022 in JAMA Cardiology. As background, the authors noted, “Statin-associated muscle symptoms (SAMS) are… read more.
Birthing women denied nitrous oxide (‘laughing gas’) to relieve labour pain during the COVID-19 pandemic have turned to opioids instead, without any adverse outcomes for mother or child,… read more.
A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Exploring the clinical effect… read more.
Pain affects people across a wide range of specialties and there is increasing evidence to suggest that medicines might not always be the answer. In this series of… read more.
Effective management of chronic pain calls for an holistic approach and could draw on skills developed in the management of other chronic conditions, says Professor Roger Knaggs (Specialist… read more.
As incoming President of the British Pain Society Professor Roger Knaggs (Specialist Pharmacist in pain management, Nottingham) is keen to find ways to help and support healthcare professionals… read more.
Better education about opioids and careful patient monitoring could be the keys to reducing opioid-dependence and effective pain management, according to Professor Roger Knaggs (Specialist Pharmacist in pain… read more.
Pain affects people with a wide range of conditions and, with increasing evidence to suggest that medicines might not always be the answer, there is more need than… read more.
Opioids are the gold standard for treatment of chronic and acute pain; however, their use may result in significant gastrointestinal side effects, including nausea, vomiting, and constipation. The… read more.
Opioids are a cornerstone of cancer pain management, but there is a lack of consensus on how to treat pain in cancer patients who also have struggled with… read more.
Heron Therapeutics, Inc., announced that Health Canada has issued a Notice of Compliance (NOC) to commercialize Zynrelef (bupivacaine and meloxicam extended-release solution) for instillation into the surgical wound… read more.
Lidocaine infusions appear to offer significant relief to patients with refractory chronic migraine. Researchers reported this finding on May 23, 2022 in the journal Regional Anesthesia & Pain Medicine…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
